Tumour-derived Exosomes or Microvesicles: Another Mechanism of Tumour Escape from the Host Immune System?

Overview

Journal Br J Cancer

Specialty Oncology

Date 2005 Feb 11

PMID 15702078

Citations 35

Authors

T L Whiteside

Affiliations

Soon will be listed here.

Citing Articles

Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review.

Koltai T, Reshkin S, Carvalho T, Di Molfetta D, Greco M, Alfarouk K Cancers (Basel). 2022; 14(10).

PMID: 35626089 PMC: 9139729. DOI: 10.3390/cancers14102486.

Exosome-Mediated Insulin Delivery for the Potential Treatment of Diabetes Mellitus.

Rodriguez-Morales B, Antunes-Ricardo M, Gonzalez-Valdez J Pharmaceutics. 2021; 13(11).

PMID: 34834285 PMC: 8621140. DOI: 10.3390/pharmaceutics13111870.

Exosomes derived from mycobacterium tuberculosis-infected MSCs induce a pro-inflammatory response of macrophages.

Liu M, Wang Z, Ren S, Zhao H Aging (Albany NY). 2021; 13(8):11595-11609.

PMID: 33872217 PMC: 8109131. DOI: 10.18632/aging.202854.

A treatise on endothelial biology and exosomes: homage to Theresa Maria Listowska Whiteside.

Ludwig N, Lotze M HNO. 2020; 68(2):71-79.

PMID: 31965194 DOI: 10.1007/s00106-019-00803-1.

Microvesicles and chemokines in tumor microenvironment: mediators of intercellular communications in tumor progression.

Bian X, Xiao Y, Wu T, Yao M, Du L, Ren S Mol Cancer. 2019; 18(1):50.

PMID: 30925930 PMC: 6441155. DOI: 10.1186/s12943-019-0973-7.

References

Thery C, Zitvogel L, Amigorena S . Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002; 2(8):569-79. DOI: 10.1038/nri855. View

Whiteside T . Tumor-induced death of immune cells: its mechanisms and consequences. Semin Cancer Biol. 2002; 12(1):43-50. DOI: 10.1006/scbi.2001.0402. View

Morelli A, Larregina A, Shufesky W, Sullivan M, Stolz D, Papworth G . Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood. 2004; 104(10):3257-66. DOI: 10.1182/blood-2004-03-0824. View

Taylor D, Taylor C, Jiang C, Black P . Characterization of plasma membrane shedding from murine melanoma cells. Int J Cancer. 1988; 41(4):629-35. DOI: 10.1002/ijc.2910410425. View

Chaput N, Schartz N, Andre F, Zitvogel L . Exosomes for immunotherapy of cancer. Adv Exp Med Biol. 2003; 532:215-21. DOI: 10.1007/978-1-4615-0081-0_17. View

Thery C, Regnault A, Garin J, Wolfers J, Zitvogel L, Ricciardi-Castagnoli P . Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J Cell Biol. 1999; 147(3):599-610. PMC: 2151184. DOI: 10.1083/jcb.147.3.599. View

Taylor D, Gercel-Taylor C, Lyons K, Stanson J, Whiteside T . T-cell apoptosis and suppression of T-cell receptor/CD3-zeta by Fas ligand-containing membrane vesicles shed from ovarian tumors. Clin Cancer Res. 2003; 9(14):5113-9. View

Taylor D, Homesley H, Doellgast G . "Membrane-associated" immunoglobulins in cyst and ascites fluids of ovarian cancer patients. Am J Reprod Immunol (1980). 1983; 3(1):7-11. DOI: 10.1111/j.1600-0897.1983.tb00204.x. View

Kim J, Wieckowski E, Taylor D, Reichert T, Watkins S, Whiteside T . Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes. Clin Cancer Res. 2005; 11(3):1010-20. View

10.

Andreola G, Rivoltini L, Castelli C, Huber V, Perego P, Deho P . Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J Exp Med. 2002; 195(10):1303-16. PMC: 2193755. DOI: 10.1084/jem.20011624. View

11.

Johnstone R, Adam M, Hammond J, Orr L, Turbide C . Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem. 1987; 262(19):9412-20. View

12.

Taylor D, Chou I, Black P . Isolation of plasma membrane fragments from cultured murine melanoma cells. Biochem Biophys Res Commun. 1983; 113(2):470-6. DOI: 10.1016/0006-291x(83)91749-7. View

13.

Taylor D, Gercel-Taylor C . Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects. Br J Cancer. 2005; 92(2):305-11. PMC: 2361848. DOI: 10.1038/sj.bjc.6602316. View